Govt, pharma industry lean on trade talks to soften Trump’s drug tariff plan

From the publisher

The US is India’s largest pharmaceutical export market, accounting for $9.47 billion, or 30.4%, of the country’s total pharmaceutical exports of $31.12 billion in FY26, making the proposed tariffs one of the biggest risks facing the sector.

The source's own excerpt, unedited